Chapter 16.2
Haemochromatosis
Antonello Pietrangelo,
Antonello Pietrangelo
Search for more papers by this authorAntonello Pietrangelo,
Antonello Pietrangelo
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Pietrangelo A (2004) Hereditary hemochromatosis — a new look at an old disease. N Engl J Med 350, 2383–2397.
- Trousseau A (1865) Glycosurie; diabete sucre. Clin Med Hotel Paris 2, 663–698.
- Troisier M (1871) Diabète sucré. Bull Soc Anat Paris 44, 231–235.
- von Recklinghausen FD (1889) Uber Haemochromatose. Taggebl Versamm Dtsch Naturforsch Aerzte Heidelberg 62, 324–325.
- Sheldon JH (1935) Hemochromatosis. London: Oxford University Press.
- Simon M Pawlotsky Y Bourel M et al. (1975) [Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen]. Nouv Presse Med 4, 1432.
- Simon M Le Mignon L Fauchet R et al. (1987) A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 41, 89–105.
- Feder JN Gnirke A Thomas W et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 13, 399–408.
- Pietrangelo A (1998) Hemochromatosis 1998: is one gene enough. J Hepatol 29, 502–509.
- Lebron JA Bennett MJ Vaughn DE et al. (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111–123.
- Feder JN Penny DM Irrinki A et al. (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95, 1472–1477.
- Gross CN Irrinki A Feder JN et al. (1998) Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 273, 22068–22074.
- Zhang AS Davies PS Carlson HL et al. (2003) Mechanisms of HFE-induced regulation of iron homeostasis: insights from the W81A HFE mutation. Proc Natl Acad Sci USA 100, 9500–9505.
- Davies PS Zhang AS Anderson EL et al. (2003) Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochem J 373, 145–153.
- Waheed A Parkkila S Zhou XY et al. (1997) Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta[2]-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 94, 12384–12389.
- Kawabata H Yang R Hirama T et al. (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274, 20826–20832.
- Kawabata H Germain RS Vuong PT et al. (2000) Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem 275, 16618–16625.
- West AP Jr, Bennett MJ Sellers VM et al. (2000) Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem 275, 38135–38138.
- Papanikolaou G Samuels ME Ludwig EH et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genet 36, 77–82.
- Lin L Goldberg YP Ganz T (2005) Competitive regulation of hep-cidin mRNA by soluble and cell-associated hemojuvelin. Blood 106, 2884–2889.
- Krause A Neitz S Magert HJ et al. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147–150.
- Park CH Valore EV Waring AJ et al. (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806–7810.
- Pigeon C Ilyin G Courselaud B et al. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811–7819.
- Ganz T (2005) Hepcidin — a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18, 171–182.
- Roetto A Papanikolaou G Politou M et al. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genet 33, 21–22.
- Nemeth E Tuttle MS Powelson J et al. (2004) Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.
- Bridle KR Frazer DM Wilkins SJ et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673.
- Gehrke SG Kulaksiz H Herrmann T et al. (2003) Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron. Blood 102, 371–376.
- Nemeth E Roetto A Garozzo G et al. (2005) Hepcidin is decreased in TFR2-Hemochromatosis. Blood 105, 1803–1806.
- Papanikolaou G Tzilianos M Christakis JI et al. (2005) Hepcidin in iron overload disorders. Blood 105, 4103–4105.
- Muckenthaler M Roy CN Custodio AO et al. (2003) Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nature Genet 34, 102–107.
- Kawabata H Fleming RE Gui D et al. (2005) Expression of hepcidin is down-regulated in Tf R2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105, 376–381.
- Niederkofler V Salie R Arber S (2005) Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overloa. J Clin Invest 115, 2180–2186.
- Huang FW Pinkus JL Pinkus GS et al. (2005) A mouse model of juvenile hemochromatosis. J Clin Invest 115, 2187–2191.
- Nicolas G Viatte L Lou DQ et al. (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature Genet 34, 97–101.
- Merryweatherclarke AT Pointon JJ Shearman JD et al. (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34 (4), 275–278.
- Powell LW Summers KM Board PG et al. (1990) Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 98, 1625–1632.
- Bulaj ZJ Griffen LM Jorde LB et al. (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335, 1799–1805.
- Rochette J Pointon JJ Fisher CA et al. (1999) Multicentric origin of hemochromatosis gene (HFE) mutations [published erratum appears i. Am J Hum Genet 1999 May 64 (5), 1491]. Am J Hum Genet 64, 1056–1062.
- Pietrangelo A (2004) Non-HFE hemochromatosis. Hepatology 39, 21–29.
- Guyader D Jacquelinet C Moirand R et al. (1998) Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115, 929–936.
- Morrison ED Brandhagen DJ Phatak PD et al. (2003) Serum ferritin level predicts advanced hepatic fibrosis among US patients with phenotypic hemochromatosis. Ann Intern Med 138, 627–633.
- Asberg A Hveem K Thorstensen K et al. (2001) Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 36, 1108–1115.
- Olynyk JK Cullen DJ Aquilia S et al. (1999) A population-based study of the clinical expression of the hemochromatosis gene (see comments). N Engl J Med 341, 718–724.
- Bulaj ZJ Ajioka RS Phillips JD et al. (2000) Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343, 1529–1535.
- Beutler E Felitti VJ Koziol JA et al. (2002) Penetrance of 845G— A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211–218.
- Adams PC Reboussin DM Barton JC et al. (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352, 1769–1778.
- Anon (2000) EASL International Consensus Conference on Haemochromatosis — Part III. Jury document. J Hepatol 33, 496–504.
- Rivard SR Mura C Simard H et al. (2000) Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, Canada). Blood Cells Mol Dis 26, 10–14.
- De Gobbi M Roetto A Piperno A et al. (2002) Natural history of juvenile haemochromatosis. Br J Haematol 117, 973–979.
- Pietrangelo A Caleffi A Henrion J et al. (2005) Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128, 470–479.
- Tavill AS (2001) Diagnosis and management of hemochromatosis. Hepatology. 33: 1321–1328.
- Pietrangelo A (2004) The ferroportin disease. Blood Cells Mol Dis 32, 131–138.
- Pietrangelo A Montosi G Totaro A et al. (1999) Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene (see comments). N Engl J Med 341, 725–732.
- Montosi G Donovan A Totaro A et al. (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108, 619–623.
- Donovan A Brownlie A Zhou Y et al. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781.
- McKie AT Marciani P Rolfs A et al. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5, 299–309.
- Abboud S Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275, 19906–19912.
- Nemeth E Tuttle MS Powelson J et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093.
- Drakesmith H Schimanski LM Ormerod E et al. (2005) Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106, 1092–1097.
- Schimanski LM Drakesmith H Merryweather-Clarke AT et al. (2005) In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096–4102.
- De Domenico I Ward DM Nemeth E et al. (2005) The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102, 8955–8960.
- Sham RL Phatak PD West C et al. (2005) Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol Dis 34, 157–161.
- Gordeuk V Mukiibi J Hasstedt SJ et al. (1992) Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 326, 95–100.
- Moyo VM Mandishona E Hasstedt SJ et al. (1998) Evidence of genetic transmission in African iron overload. Blood 91, 1076–1082.
- Gordeuk VR Caleffi A Corradini E et al. (2003) Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene small star, filled. Blood Cells Mol Dis 31, 299–304.
- Yoshida K Furihata K Takeda S et al. (1995) A mutation in the cerulo-plasmin gene is associated with systemic hemosiderosis in humans. Nature Genet 9, 267–272.
- Harris ZL Takahashi Y Miyajima H et al. (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92, 2539–2543.
- Goode CA Dinh CT Linder MC (1989) Mechanism of copper transport and delivery in mammals: review and recent findings. Adv Exp Med Biol 258, 131–144.
- Miyajima H Takahashi Y Kamata T et al. (1997) Use of desferoxamine in the treatment of aceruloplasminemia. Ann Neurol 41, 404–407.
- Hayashi A Wada Y Suzuki T et al. (1993) Studies on familial hypo-transferrinemia — unique clinical course and molecular pathology. Am J Hum Genet 53, 201–213.
- Kato J Fujikawa K Kanda M et al. (2001) A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 69, 191–197.
- Knisely AS Mieli-Vergani G Whitington PF (2003) Neonatal hemochromatosis. Gastroenterol Clin North Am 32, 877–889.
- Cox TM Halsall DJ (2002) Hemochromatosis — neonatal and young subjects. Blood Cells Mol Dis 29, 411–417.
